Skip to main content
Springer logoLink to Springer
. 2024 Jan 29;28(3):1104–1121. doi: 10.1007/s10461-023-04222-w

The Association Between HIV-Related Stigma and the Uptake of HIV Testing and ART Among Older Adults in Rural South Africa: Findings from the HAALSI Cohort Study

Nomsa B Mahlalela 1,2,, Jennifer Manne-Goehler 1,3,4, Daniel Ohene-Kwofie 1, Leslie B Adams 5,6, Livia Montana 5,7, Kathleen Kahn 1, Julia K Rohr 5, Till Bärnighausen 1,8,9, Francesc X Gómez-Olivé 1
PMCID: PMC10896802  PMID: 38286975

Abstract

HIV testing and antiretroviral therapy (ART) remain critical for curbing the spread of HIV/AIDS, but stigma can impede access to these services. Using data from the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI), we used a multivariable logistic regression to examine the correlation between HIV-related stigma, HIV testing and ART uptake in older adults. We used four questions to measure stigma, with three assessing social stigma (reflecting social distancing preferences) and one assessing anticipated stigma (disclosure concern). We combined the three social stigma questions to generate a social stigma score ranging from 0 to 3, with higher scores indicating higher stigma. Anticipated stigma was prevalent 85% (95% CI 0.84–0.86), and social stigma was also frequent 25% (95% CI 0.24–0.27). Higher social stigma scores correlated with decreased HIV testing for all participants with social stigma. Compared to those with a score of 0, odds of testing decreased with higher stigma scores (OR = 0.66, 95% CI 0.53–0.81, p = 0.000) for a score of 1 and (OR = 0.56, 95% CI 0.38–0.83, p = 0.004) for a score of 3. ART uptake also decreased with higher social stigma scores among people living with HIV (PLWH), although it was significant for those with a score of 2 (OR = 0.41, 95% CI 0.19–0.87, p = 0.020). These findings emphasize that HIV-related stigma hampers testing and ART uptake among older adults in rural South Africa. Addressing stigma is crucial for improving testing rates, early diagnosis, and treatment initiation among the older population and achieving UNAIDS 95–95–95 targets.

Supplementary Information

The online version contains supplementary material available at 10.1007/s10461-023-04222-w.

Keywords: HIV-related stigma, Antiretroviral therapy, HIV testing, Older adults, South Africa, HAALSI

Introduction

The HIV/AIDS epidemic remains a significant public health challenge globally, with approximately 39 million people living with HIV (PLWH), and 1.3 million new infections in 2022 [1]. South Africa continues to have a high HIV prevalence of 13.7% among all age groups, accounting for about 8.2 million PLWH [2]. Notably, the number of PLWH aged 50 and older is increasing globally, indicating an aging HIV-positive population [3]. Evidence from rural South Africa shows high HIV prevalence among older adults [46], attributed to increased life expectancy among PLWH on antiretroviral therapy (ART) and new infections occurring at older ages [3, 68]. Older adults are a growing at-risk group for HIV transmission, and their inclusion in HIV prevention and care treatment programs is crucial for reaching the UNAIDS 95–95–95 targets to combat the HIV epidemic.

Despite the decline in sexual activity with age, evidence from various countries including South Africa indicates that a significant number of older adults aged 50 and above are sexually active and engage in similar HIV risk behaviors as young people [915]. Studies have shown lack of condom use among many older adults with multiple sexual partners [12, 13, 16]. It is crucial for older people to understand HIV transmission risks and be actively included in prevention strategies and HIV services [11]. Early diagnosis and treatment are essential components of the global HIV response to prevent further HIV transmissions [17]. Globally, there has been a significant improvement across the HIV testing and treatment cascade. Among all PLWH, 86% knew their status, 76% were accessing treatment and 71% were virally suppressed in 2022 [1]. While South Africa has made progress in achieving the UNAIDS 90–90–90 targets [18], there are still challenges in linking people to care and retaining them in treatment. Testing rates also remain low among certain high-risk populations, including older adults, despite efforts to expand access to HIV testing and treatment. Community and home-based outreach HIV testing programs aimed at reducing late diagnoses have revealed inadequate testing among older populations due to misconceptions about their sexual activity, lower perception of HIV risk and presence of HIV-related stigma [19, 20].

HIV-related stigma encompasses negative beliefs, feelings and attitudes towards PLWH, groups associated with PLWH such as their families, and key populations at higher risk of HIV infection, such as sex workers, men who have sex with men, transgender people, and people who inject drugs [21]. HIV-related stigma can manifest in various forms, including social stigma (negative attitudes towards PLWH including desires for social distance), enacted stigma (specific acts of discrimination towards PLWH), internalized stigma (negative beliefs within PLWH about themselves) [22], and anticipated stigma (fear of negative outcomes if HIV status is disclosed) [2224]. These forms of stigma can result in social exclusion, discrimination, rejection, and fear of disclosing HIV status.

HIV remains a highly stigmatized condition because it is often linked to socially condemned behaviours that are considered high risk and associated with its transmission, such as multiple and concurrent sexual partners, homosexual intercourse, drug use and sex work [2527]. As a result of this association, PLWH often face discrimination and prejudice which often contribute to the ongoing stigma surrounding HIV. Fear and misinformation about HIV transmission also play a significant role in reinforcing unfounded fears of casual contact with PLWH. This perpetuate harmful myths about HIV, leading to the continuation of stigma associated with the virus. HIV-related stigma often intersects with other forms of stigmatization such as homophobia, gender discrimination, discrimination against marginalized populations, and racism further creating complex challenges for PLWH. Intersecting stigmas can result in social exclusion, limited access to healthcare and support, increased psychological distress, and reduced opportunities for employment and personal relationships.

HIV-related stigma remains a significant barrier to controlling the HIV epidemic. Stigmatizing attitudes discourage individuals from getting tested for HIV, seeking medical care, and adhering to treatment [7, 2832]. Fear of stigma can prevent people from disclosing their HIV status to family, friends, or sexual partners, leading to increased feelings of isolation and secrecy. Stigma also affects mental health and overall well-being for PLWH, and present challenges for those in need of health care services including older adults [32]. Overcoming stigma requires comprehensive strategies that promote education, awareness, and empathy, fostering a supportive environment and understanding society.

There is a relatively small number of studies on HIV-related stigma among older adults, despite the increasing number of older adults living with HIV. The majority of research excludes older subjects or ignores age as a variable [7]. Older adults experienced the HIV epidemic differently, with historical perspectives that may influence their experiences of stigma. HIV-related stigma has been linked to adverse psychological and social outcomes, which may be particularly important for older adults due to their increased vulnerability. Understanding HIV-related stigma in older adults remains crucial and can inform interventions to support their mental health and overall well-being. This study aims to examine the association between HIV-related stigma and HIV testing and ART uptake among older adults living with HIV in rural South Africa, using data from the HAALSI study.

Methods

Study Site

The study was conducted in the Agincourt Health and Demographic Surveillance System (HDSS) site located in Mpumalanga province, South Africa, which is run by the MRC/Wits Rural Public Health and Health Transitions Research Unit. The HDSS conducts an annual census and collects vital events data for all household members in the area, including births, deaths, and migration [33]. Overall, Agincourt is a rural area with underdeveloped education system, limited access to employment opportunities, insufficient healthcare and sanitation, and experiences high rates of labor migration [34, 35].

Study Population

The HAALSI study is a longitudinal population-based cohort study focused on studying health, aging, and well-being of older people [36]. The baseline assessment data were collected between November 2014 and November 2015. To be included in the study, participants needed to be at least 40 years old as of 1 July 2014 and have lived in the study area for the 12 months preceding the 2013 HDSS census round. A random sample of eligible men and women was obtained from the HDSS database, resulting in a total of 5059 participants (2345 men and 2714 women). Data collection involved in-person interviews conducted by locally trained fieldworkers in the local language (Xi-Tsonga) using a computer-assisted personal interviewing (CAPI) system. Additional details are described elsewhere [36]. Follow-up interviews were conducted from 2018 to 2019 (wave 2). During this period, 602/5059 participants died, leaving 4457 participants eligible for follow-up. Out of these, 4176 participants completed the follow-up interviews, resulting in a response rate of 94%. For the analysis of HIV-related stigma, 3849 participants (92%) responded to all three social stigma questions and were eligible for inclusion. Participants with missing responses (n = 10) or those who refused to answer the stigma questions (n = 317) were excluded from the analysis because we could not generate a social stigma score for them.

Measures

HIV-Related Stigma

HIV-related stigma was assessed using a standard indicator commonly used in UNAIDS general population surveys, Demographic and Health Surveys (DHS) AIDS module, and Family Health International Behavioral Surveillance Surveys (FHI BSS) [37]. The indicator consists of three questions assessing social stigma (desires for social distance from PLWH): (1) “If a member of your family became sick with the AIDS virus, would you be willing to care for him or her in your household?”, (2) “If you knew that a shopkeeper or food seller had the AIDS virus, would you buy fresh vegetables from them?”, (3) “If a female teacher has the AIDS virus but is not sick, should she be allowed to continue teaching in school?”. Negative responses (No) to these questions indicate a preference for social distancing from PLWH [38]. Similar to [39], we defined a respondent as having preferences for social distancing if he/she had a negative response to at least one of the three questions. Each negative response was given a score of one point, and the scores from the three questions were summed to create an overall social stigma score ranging from 0 to 3, with higher scores indicating higher levels of social stigma. The indicator also includes one question assessing anticipated stigma (disclosure concern), “If a member of your family became infected with the AIDS virus, would you want it to remain a secret?.” Positive responses (Yes) to this question reflect the fear of disclosing a hypothetical HIV infection within a family [40], or fear of negative consequences such as rejection or condemnation, if a family member’s HIV positive status were revealed to others [41].

Ever Tested for HIV

During wave 2 data collection, participants were asked whether they had ever tested for HIV, with response options of “Yes” and “No”. Participants with missing responses (n = 12) were excluded from the analysis. To ensure accurate estimation of HIV testing rates and to avoid potential bias due to over reporting, participants with a confirmed HIV diagnosis from the dried blood spots (DBS) testing (n = 715) were also excluded from this specific analysis.

HIV and ART Uptake Status

During the in-person home interviews, DBS samples were collected from the study participants. After the data collection period, these DBS samples underwent biological testing for various parameters related to HIV. The testing included checking for the presence of HIV antibodies, measuring viral load, and assessing exposure to emtricitabine (FTC) or lamivudine (3TC), which are components of the first- and second-line ART regimens used in the South African HIV program [36, 42].

Data Analysis

The analysis was conducted using Stata 17 [43]. Descriptive statistics were used to describe the characteristics of the study population. To assess respondent’s attitudes towards PLWH, the proportion of men and women answering “yes” to at least one of the three social stigma questions was calculated. Pearson’s chi-square tests were used to compare proportions. Means in social stigma were calculated using the social stigma score for key socio-demographic groups and the three major “HIV cascade” groups: HIV-negative, HIV+ on ART, and HIV+ no ART, and compared differences between two means using t-tests and three means using one-way ANOVA where applicable. Descriptive analysis was conducted to assess differences in anticipated stigma by key several socio-demographics. Logistic regression analysis was used to examine the association between the outcome of interest (ever tested for HIV) and our independent variables (social stigma and anticipated stigma), while controlling for several confounding variables such as sex, age, education, marital status, employment, household size, and wealth asset index. The same model was applied for the outcome of ART uptake for PLWH. Models were further stratified by age and sex to explore associations in these subgroups. A significance threshold of p < 0.05 was used to determine statistical significance in all analyses.

Results

The study analysed sample characteristics by sex and included 3,849 participants, with 56% being women (see Table 1). The overall mean age of the participants was 64.6 years (SD = 12.2). Women had lower levels of education (47.5% vs 38.2%, χ2 (2) = 39.778, p = 0.000) and more frequently reported being widowed (49.6% vs 14.7%, χ2 (3) = 560.617, p = 0.000), while men were more likely to be currently married or living with a partner (63.7% vs 32.5%, χ2 (3) = 560.617, p = 0.000). Unemployment was higher among women compared to men (63.0% vs 54.2%, χ2 (2) = 35.179, p = 0.000). Men had a higher percentage of living in single-member households (15.5% vs 7.7%, χ2 (3) = 63.645, p = 0.000) and were more likely to live in households ranked lowest in the wealth asset index (28.0% vs 23.6%, χ2 (4) = 12.022, p = 0.017). Uptake of HIV testing was similar for both men and women based on self-report, and although not significant, HIV prevalence was slightly higher for women 24.6% compared to men 23.9% based on the DBS HIV test results.

Table 1.

Socio-demographic characteristics by sex among HAALSI participants (N = 3849)

Variables Total % % Men (n = 1693) % Women (n = 2156) Chi-square (χ2) p value
Age group χ2 (4) = 8.290 0.082
 40–49 12.4 12.3 12.4
 50–59 25.6 23.5 27.3
 60–69 28.6 29.7 27.8
 70–79 20.7 21.7 19.9
 80+ 12.7 12.9 12.6
 Mean age 64.6 65.1 64.3
Education χ2 (2) = 39.778 0.000
 No formal 43.4 38.2 47.5
 At least some primary (1–7 years) 35.3 36.8 34.0
 Secondary or more (8+ years) 21.3 25.0 18.5
Marital status χ2 (3) = 560.617 0.000
 Never married 7.2 9.6 5.4
 Separated or divorced 12.3 12.1 12.5
 Widowed 34.2 14.7 49.6
 Currently married or living with partner 46.2 63.7 32.5
Employment status χ2 (2) = 35.179 0.000
 Unemployed 59.1 54.2 63.0
 Employed (full-time or part-time) 17.0 20.3 14.4
 Retired 23.9 25.5 22.6
Household size χ2 (3) = 63.645 0.000
 Living alone 11.1 15.5 7.7
 Living with another person 10.4 10.9 9.9
 Living in 3–6 person 43.7 40.6 46.2
 Living in 7+ person 34.8 33.0 36.2
Wave 2 wealth asset index χ2 (4) = 12.022 0.017
 Index 1 (lower) 25.5 28.0 23.6
 Index 2 26.5 24.5 28.1
 Index 3 6.1 6.1 6.2
 Index 4 13.6 13.4 13.8
 Index 5 (higher) 28.2 28.1 28.4
Wave 2 ever tested for HIV (self-report) χ2 (1) = 0.163 0.687
 Yes 76.9 76.6 77.2
 No 23.1 23.4 22.8
Wave 2 DBS HIV test result χ2 (2) = 1.193 0.551
 HIV+ 24.3 23.9 24.6
 HIV− 75.2 75.7 74.8
 Indeterminate 0.5 0.4 0.7

Missing data: Ever tested for HIV (n = 12), Wave 2 DBS HIV test result (n = 902)

The study found that the majority of both men and women had accepting attitudes towards PLWH (see Fig. 1). Over 90% believed that a female teacher with the AIDS virus but not sick should be allowed to continue teaching in school. More than 80% reported that they would be willing to care for a family member who became sick with the AIDS virus in their household. Additionally, almost 80% reported they would buy fresh vegetables from a shopkeeper they knew had the AIDS virus. Regarding the social stigma questions, 3% (n = 128) of older adults answered ‘no’ to all three stigma questions (scored 3 points); 8% (n = 308) answered ‘no’ to two of the questions (scored 2 points); 14% (n = 536) answered ‘no’ to one of the questions (scored 1 point); and 75% (n = 2877) answered ‘yes’ to all three questions (scored 0 points). For the anticipated stigma question, only a small proportion of both men (14.9%) and women (14.7%) reported that they would not want it to remain a secret if a family member became infected with the AIDS virus.

Fig. 1.

Fig. 1

Accepting attitudes toward PLWH by sex (N = 3849)

The study found that women significantly tend to have less social stigma compared to men (mean = 0.38 vs 0.42, t = 1.694, p = 0.045) (see Table 2). Younger respondents (mean = 0.26, F = 27.57, p = 0.000), those with secondary or more education (mean = 0.28, F = 14.46, p = 0.000), currently married or living with a partner (mean = 0.33, F = 8.35, p = 0.000), employed (mean = 0.27, F = 13.41, p = 0.000), living in 7+ person household (mean = 0.37, F = 3.35, p = 0.018), living in households with higher wealth asset index (mean = 0.33, F = 6.62, p = 0.000), those ever tested for HIV (mean = 0.35, t = − 7.684, p = 0.000), and those who tested HIV+ (mean = 0.29, F = 32.23, p = 0.000) significantly had less social stigma compared to older respondents (mean = 0.70, F = 27.57, p = 0.000), those with no formal education (mean = 0.45, F = 14.46, p = 0.000), never married (mean = 0.47, F = 8.35, p = 0.000), widowed (mean = 0.46, F = 8.35, p = 0.000), separated or divorced (mean = 0.43, F = 8.35, p = 0.000), unemployed (mean = 0.41, F = 13.41, p = 0.000), retired (mean = 0.47, F = 13.41, p = 0.000), living alone (mean = 0.50, F = 3.35, p = 0.018), in households with lower wealth asset index (mean = 0.50, F = 6.62, p = 0.000), never tested for HIV (mean = 0.57, t = − 7.684, p = 0.000), and those who tested HIV negative (mean = 0.40, F = 32.23, p = 0.000). There were no significant differences in anticipated stigma based on respondent’s covariates including sex, age group, marital status, education, employment, household size, household wealth asset index, ever tested for HIV and HIV status (see Table 3). However, there were significant differences in social stigma based on respondents’ biological HIV and ART uptake status (see Fig. 2). Older adults HIV+ on ART were significantly less likely to have social stigma compared to those HIV negative or HIV+ not on ART.

Table 2.

Variations in social stigma score by respondents’ socio-demographics (N = 3849)

Variables Mean (SD) p value
Sex t = 1.694 0.045
 Male 0.42 (0.80)
 Female 0.38 (0.76)
Age group F = 27.57 0.000
 40–49 0.26 (0.64)
 50–59 0.32 (0.70)
 60–69 0.35 (0.71)
 70–79 0.46 (0.82)
 80+ 0.70 (0.98)
Education F = 14.46 0.000
 No formal 0.45 (0.83)
 At least some primary (1–7 years) 0.40 (0.77)
 Secondary or more (8+ years) 0.28 (0.63)
Marital status F = 8.35 0.000
 Never married 0.47 (0.82)
 Separated or divorced 0.43 (0.81)
 Widowed 0.46 (0.83)
 Currently married or living with partner 0.33 (0.71)
Employment status F = 13.41 0.000
 Unemployed 0.41 (0.78)
 Employed (full-time or part-time) 0.27 (0.64)
 Retired 0.47 (0.83)
Household size F = 3.35 0.018
 Living alone 0.50 (0.91)
 Living with another person 0.42 (0.81)
 Living in 3–6 person 0.39 (0.75)
 Living in 7+ person 0.37 (0.74)
Wave 2 wealth asset index F = 6.62 0.000
 Index 1 (lower) 0.50 (0.86)
 Index 2 0.39 (0.76)
 Index 3 0.40 (0.79)
 Index 4 0.38 (0.76)
 Index 5 (higher) 0.33 (0.70)
Wave 2 ever tested for HIV (self-report) t = − 7.684 0.000
 Yes 0.35 (0.73)
 No 0.57 (0.89)
Wave 2 DBS HIV test result F = 32.23 0.000
 HIV+ 0.29 (0.68)
 HIV− 0.40 (0.78)

Table 3.

Anticipated stigma by socio-demographic characteristics (N = 3849)

Variables % Saying will keep family member HIV status secret Chi-square (χ2) p value
Sex χ2 (1) = 0.010 0.920
 Male 85.17
 Female 85.29
Age group χ2 (4) = 0.448 0.978
 40–49 85.29
 50–59 84.79
 60–69 85.75
 70–79 85.28
 80+ 84.87
Education χ2 (2) = 2.600 0.273
 No formal 86.29
 At least some primary (1–7 years) 84.52
 Secondary or more (8+ years) 84.29
Marital status χ2 (3) = 6.036 0.110
 Never married 82.01
 Separated or divorced 83.37
 Widowed 84.88
 Currently married or living with partner 86.51
Employment status χ2 (2) = 1.936 0.380
 Unemployed 84.58
 Employed (full-time or part-time) 86.24
 Retired 86.17
Household size χ2 (3) = 2.149 0.542
 Living alone 83.41
 Living with another person 84.96
 Living in 3–6 person 85.03
 Living in 7+ person 86.17
Wave 2 wealth asset index χ2 (4) = 6.623 0.157
 Index 1 (lower) 84.11
 Index 2 86.26
 Index 3 88.98
 Index 4 86.45
 Index 5 (higher) 83.90
Wave 2 ever tested for HIV (self-report) χ2 (1) = 2.552 0.110
 Yes 86.44
 No 84.85
Wave 2 DBS HIV test result χ2 (2) = 0.304 0.859
 HIV+ 86.01
 HIV− 86.05

Fig. 2.

Fig. 2

Social stigma by biological HIV and ART uptake status (N = 2931)

In the multivariable logistic regression analysis, social stigma was significantly associated with lower testing rates (OR = 0.66, 95% CI 0.53–0.81, p = 0.000), (OR = 0.61, 95% CI 0.47–0.79, p = 0.000), (OR = 0.56, 95% CI 0.38–0.83, p = 0.004) (see Table 4). No significant associations in testing were observed for sex and employment status. Age was a significant factor affecting testing, with older age groups significantly showing lower testing rates (OR = 0.46, 95% CI 0.32–0.65, p = 0.000), (OR = 0.33, 95% CI 0.23–0.48, p = 0.000) compared to younger age groups. Marital status and educational attainment also played a significant role in testing rates, with higher testing observed among those who were currently married (OR = 2.58, 95% CI 1.92–3.47, p = 0.000), separated or divorced (OR = 2.13, 95% CI 1.50–3.06, p = 0.000), widowed (OR = 2.07, 95% CI 1.52–2.83, p = 0.000), and those with some primary (OR = 1.22, 95% CI 1.02–1.47, p = 0.032), and secondary or more education (OR = 1.32, 95% CI 1.02–1.72, p = 0.035). Household size was only significantly associated with lower HIV testing among those living in households with 7 + people (OR = 0.71, 95% CI 0.53–0.95, p = 0.021). Conversely, HIV testing rates were higher among those in the wealth asset index 2 (OR = 1.28, 95% CI 1.03–1.58, p = 0.027) and higher (OR = 1.38, 95% CI 1.08–1.74, p = 0.008) compared to the lower wealth asset index category.

Table 4.

Association between social stigma and self-report HIV testing among older adults (N = 3837)

Ever tested Odd ratio 95% Conf. interval p value
Social stigma score
 0 REF REF REF
 1 0.66 (0.53–0.81) 0.000
 2 0.61 (0.47–0.79) 0.000
 3 0.56 (0.38–0.83) 0.004
Sex
 Male REF REF REF
 Female 1.08 (0.90–1.30) 0.416
Age group
 40–49 REF REF REF
 50–59 0.78 (0.57–1.07) 0.116
 60–69 0.73 (0.53–1.02) 0.067
 70–79 0.46 (0.32–0.65) 0.000
 80+ 0.33 (0.23–0.48) 0.000
Marital status
 Never married REF REF REF
 Separated or divorced 2.13 (1.50–3.06) 0.000
 Widowed 2.07 (1.52–2.83) 0.000
 Currently married or living with partner 2.58 (1.92–3.47) 0.000
Education
 No formal REF REF REF
 Some primary (1–7 years) 1.22 (1.02–1.47) 0.032
 Secondary or more (8+ years) 1.32 (1.02–1.72) 0.035
Employment
 Unemployed REF REF REF
 Employed (part or full time) 1.07 (0.83–1.37) 0.592
 Retired 0.89 (0.74–1.08) 0.249
Household Size
 Living alone REF REF REF
 Living with another person 0.92 (0.66–1.29) 0.664
 Living in 3–6-person household 1.02 (0.77–1.35) 0.894
 Living in 7+ person household 0.71 (0.53–0.95) 0.021
Wave 2 wealth asset index
 Index 1 (lower) REF REF REF
 Index 2 1.28 (1.03–1.58) 0.027
 Index 3 0.89 (0.65–1.27) 0.490
 Index 4 1.07 (0.82–1.38) 0.613
 Index 5 (higher) 1.38 (1.08–1.74) 0.008

Anticipated stigma was associated with higher HIV testing, although this association was not statistically significant (see Table 5). Age remained a significant factor, with significantly lower testing rates observed among those in older age groups (OR = 0.71, 95% CI 0.51–0.99, p = 0.044), (OR = 0.44, 95% CI 0.31–0.62, p = 0.000), (OR = 0.30, 95% CI 0.20–0.43, p = 0.000). Marital status played a significant role in HIV testing rates, with significantly higher testing rates observed among those currently married (OR = 2.68, 95% CI 1.99–3.59, p = 0.000), separated or divorced (OR = 2.14 95% CI 1.51–3.04, p = 0.000), widowed (OR = 2.10, 95% CI 1.54–2.87, p = 0.000) compared to those never married. Additionally, HIV testing was higher among individuals with some primary education (OR = 1.22, 95% CI 1.01–1.46, p = 0.034),  secondary or more education (OR = 1.34, 95% CI 1.03–1.73, p = 0.029), and those in wealth asset index 2 (OR = 1.30, 95% CI 1.05–1.61, p = 0.017) and higher wealth asset index (OR = 1.42, 95% CI 1.12–1.80, p = 0.004) compared to those with no formal education and those in lower wealth asset index category.

Table 5.

Association between anticipated stigma and self-report HIV testing among older adults (N = 3837)

Ever tested Odds ratio 95% Conf. interval p value
0 REF REF REF
1. Anticipated stigma 1.19 (0.96–1.47) 0.106
Sex
 Male REF REF REF
 Female 1.09 (0.92–1.31) 0.321
Age
 40–49 REF REF REF
 50–59 0.76 (0.56–1.05) 0.094
 60–69 0.71 (0.51–0.99) 0.044
 70–79 0.44 (0.31–0.62) 0.000
 80+ 0.30 (0.20–0.43) 0.000
Marital status
 Never married REF REF REF
 Separated or divorced 2.14 (1.51–3.04) 0.000
 Widowed 2.10 (1.54–2.87) 0.000
 Currently married or living with partner 2.68 (1.99–3.59) 0.000
Education
 No formal REF REF REF
 Some primary (1–7 years) 1.22 (1.01–1.46) 0.034
 Secondary or more (8 + years) 1.34 (1.03–1.73) 0.029
Employment
 Unemployed REF REF REF
 Employed (part or full time) 1.08 (0.84–1.39) 0.534
 Retired 0.89 (0.74–1.08) 0.253
Household size
 Living alone REF REF REF
 Living with one other person 0.92 (0.66–1.29) 0.630
 Living in 3–6 person household 1.01 (0.76–1.32) 0.971
 Living in 7+ person household 0.70 (0.53–0.93) 0.016
Wave 2 wealth asset index
 Index 1 (lower) REF REF REF
 Index2 1.30 (1.05–1.61) 0.017
 Index3 0.90 (0.64–1.26) 0.545
 Index4 1.09 (0.84–1.42) 0.519
 Index 5 (higher) 1.42 (1.12–1.80) 0.004

In the multivariable logistic regression analysis, social stigma was significantly associated with lower ART uptake, particularly among those with a stigma score of 2 (OR = 0.41, 95% CI 0.19–0.87, p = 0.020) (see Table 6). No significant associations were found between ART uptake and sex, age group, education, and household size. However, significant associations were observed for marital status, with higher ART uptake among those widowed (OR = 2.73, 95% CI 1.33–5.61, p = 0.006) and currently married or living with a partner (OR = 2.21, 95% CI 1.09–4.50, p = 0.028) compared to those never married. ART uptake was also significantly higher among individuals in wealth asset index 3 (OR = 3.45, 95% CI 1.13–10.50, p = 0.029) compared to those in lower wealth asset index. On the other hand, individuals who were retired had a significantly lower ART uptake (OR = 0.54, 95% CI 0.29–1.01, p = 0.054). For anticipated stigma, no significant associations were observed for ART uptake based on sex, age, education, and employment (see Table 7). However, ART uptake was significantly higher among those widowed (OR = 2.92, 95% CI 1.42–5.98, p = 0.003), currently married or living with a partner (OR = 2.39, 95% CI 1.18–4.83, p = 0.016), and those in wealth asset index 3 (OR = 3.49, 95% CI 1.15–10.57, p = 0.027). Conversely, ART uptake was significantly lower among those living in households with 7 + people (OR = 0.49, 95% CI 0.25–0.99, p = 0.047).

Table 6.

Association between social stigma and ART uptake among older adults living with HIV (N = 715)

ART uptake Odds ratio 95% Conf. interval p value
Social stigma score
 0 REF REF REF
 1 0.83 (0.45–1.53) 0.556
 2 0.41 (0.19–0.87) 0.020
 3 0.44 (0.15–1.23) 0.125
Sex
 Male REF REF REF
 Female 1.03 (0.65–1.63) 0.894
Age group
 40–49 REF REF REF
 50–59 0.97 (0.57–1.64) 0.898
 60–69 1.39 (0.76–2.53) 0.283
 70–79 1.39 (0.59–3.28) 0.455
 80+ 2.71 (0.55–13.34) 0.221
Marital status
 Never married REF REF REF
 Separated or divorced 1.15 (0.57–2.32) 0.706
 Widowed 2.73 (1.33–5.61) 0.006
 Currently married or living with partner 2.21 (1.09–4.50) 0.028
Education
 No formal REF REF REF
 Some primary (1–7 years) 0.85 (0.53–1.37) 0.511
 Secondary or more (8+ years) 1.02 (0.57–1.81) 0.951
Employment
 Unemployed REF REF REF
 Employed (part or full time) 0.66 (0.40–1.07) 0.090
 Retired 0.54 (0.29–1.01) 0.054
Household size
 Living alone REF REF REF
 Living with another person 1.22 (0.51–2.94) 0.654
 Living in 3–6 person 0.85 (0.44–1.64) 0.631
 Living in 7+ person 0.53 (0.26–1.06) 0.071
Wave 2 wealth asset index
 Index 1 (lower) REF REF REF
 Index 2 1.27 (0.75–2.16) 0.374
 Index 3 3.45 (1.13–10.50) 0.029
 Index 4 1.18 (0.59–2.35) 0.634
 Index 5 (higher) 1.22 (0.68–2.18) 0.510

Table 7.

Association between anticipated stigma and ART uptake among older adults living with HIV (N = 715)

ART uptake Odds ratio 95% Conf. interval p value
0 REF REF REF
1. Anticipated stigma 1.50 (0.89–2.54) 0.129
Sex
 Male REF REF REF
 Female 1.09 0.70–1.71) 0.694
Age
 40–49 REF REF REF
 50–59 0.96 (0.57–1.63) 0.885
 60–69 1.35 (0.74–2.47) 0.323
 70–79 1.31 (0.55–3.09) 0.542
 80+ 2.58 (0.53–12.64) 0.241
Marital status
 Never married REF REF REF
 Separated or divorced 1.18 (0.59–2.38) 0.636
 Widowed 2.92 (1.42–5.98) 0.003
 Currently married or living with partner 2.39 (1.18–4.83) 0.016
Education
 No formal REF REF REF
 Some primary (1–7 years) 0.82 (0.51–1.32) 0.421
 Secondary or more (8+ years) 0.98 (0.55–1.75) 0.959
Employment
 Unemployed REF REF REF
 Employed (part or full time) 0.70 (0.43–1.14) 0.149
 Retired 0.56 (0.30–1.03) 0.061
Household size
 Living alone REF REF REF
 Living with one other person 1.23 (0.51–2.96) 0.639
 Living in 3–6 person household 0.84 (0.44–1.61) 0.592
 Living in 7+ person household 0.49 (0.25–0.99) 0.047
Wave 2 wealth asset index
 Index 1 (lower) REF REF REF
 Index 2 1.29 (0.76–2.18) 0.344
 Index 3 3.49 (1.15–10.57) 0.027
 Index 4 1.28 (0.65–2.53) 0.479
 Index 5 (higher) 1.20 (0.67–2.15) 0.538

When analyzing data by age groups, the study found that social stigma was significantly associated with lower HIV testing rates among those with a stigma score of 1 in the age groups 50–59 (OR = 0.41, 95% CI 0.25–0.66, p = 0.000) and 70–79 (OR = 0.52, 95% CI 0.34–0.80, p = 0.003), and those with a score of 2 in the age groups 50–59 (OR = 0.53, 95% CI 0.30–0.96, p = 0.036) (see Table A1). HIV testing was significantly higher among females in the age groups 40–49 (OR = 1.93, 95% CI 1.05–3.55, p = 0.035) and 60–69 (OR = 1.46, 95% CI 1.02–2.08, p = 0.039), but significantly lower in the 80 + age group (OR = 0.60, 95% CI 0.36–1.00, p = 0.051). Those currently married, separated or divorced, and widowed had higher testing rates in the age groups 40–49 (OR = 2.17, 95% CI 1.07–4.40, p = 0.031), 50–59 (OR = 2.37, 95% CI 1.29–4.34, p = 0.005, (OR = 2.68, 95% CI 1.58–4.57, p = 0.000), (OR = 2.91, 95% CI 1.60–5.28, p = 0.000), 60–69 (OR = 1.97, 95% CI 1.02–3.79, p = 0.042), and 70–79 (OR = 4.69, 95% CI 1.78–12.34, p = 0.002), (OR = 2.71, 95% CI 1.26–5.85, p = 0.011), (OR = 5.31, 95% CI 2.45–11.49, p = 0.000). Education also had an impact on testing rates, with those with formal education showing higher testing rates in the age groups 50–59 (OR = 1.53, 95% CI 1.02–2.30, p = 0.042), (OR = 1.74, 95% CI 1.10–2.77, p = 0.019) and 60–69 (OR = 2.32, 95% CI 1.28–4.18, p = 0.005). Employment status did not show significant associations with HIV testing across all age groups. Household size was only significantly associated with lower testing rates among those living in 7 + person household in the 60–69 age group (OR = 0.45, 95% CI 0.24–0.82, p = 0.010). Wealth index was significantly associated with higher testing rates for those in wealth index 2 in the 40–49 age group (OR = 2.27, 95% CI 1.06–4.86, p = 0.035).

There was no significant association between anticipated stigma and HIV testing rates across all age groups (see Table A2). HIV testing was significantly higher among females in the age groups 40–49 (OR = 1.97, 95% CI 1.07–3.63, p = 0.029) and 60–69 (OR = 1.46, 95% CI 1.03–2.09, p = 0.036), but a significantly lower in the 80 + age group (OR = 0.59, 95% CI 0.36–0.98, p = 0.040). Those ever married had significantly higher testing rates in the age groups 40–49 (OR = 2.17, 95% CI 1.07–4.38, p = 0.031), 50–59 (OR = 2.23, 95% CI 1.23–4.04, p = 0.009), (OR = 2.72, 95% CI 1.61–4.60, p = 0.000), 60–69 (OR = 2.10, 95% CI 1.10–4.12, p = 0.025), and 70–79 (OR = 4.72, 95% CI 1.80–12.36, p = 0.002), (OR = 5.44, 95% CI 2.53–11.69, p = 0.000), while those widowed had significantly higher testing rates in the age groups 50–59 (OR = 2.90, 95% CI 1.61–5.24, p = 0.000) and 70–79 (OR = 2.75, 95% CI 1.29–5.87, p = 0.009). Those with more formal education showed significantly higher testing rates in the age groups 50–59 (OR = 1.65, 95% CI 1.04–2.62, p = 0.032) and 60–69 (OR = 2.29, 95% CI 1.27–4.12, p = 0.006). Employment status did not show significant associations with HIV testing across all age groups, except for lower testing rates among those retired in the age group 40–49 (OR = 0.24, 95% CI 0.06–0.99, p = 0.048). Household size was significantly associated with lower testing rates among those in 7 + person households in the age group 60–69 (OR = 0.44, 95% CI 0.24–0.80, p = 0.007), and higher testing rates were observed for those in wealth index 2 in the age group 40–49 (OR = 2.34, 95% CI 1.10–5.01, p = 0.028).

Social stigma was significantly associated with lower ART uptake among those with a social stigma score of 2 in the age groups 60–69 (OR = 0.20, 95% CI 0.04–0.91, p = 0.037) and 70–79 (OR = 0.01, 95% CI 0.00–1.03, p = 0.051) (see Table A3). No significant associations in ART uptake were observed for sex, marital status, education, and wealth index across all age groups. Employment was significantly associated with lower ART uptake only among those retired in the age group 60–69 (OR = 0.31, 95% CI 0.11–0.81, p = 0.017). Household size was significantly associated with lower ART uptake for those in 7+ person household in the age group 60–69 (OR = 0.11, 95% CI 0.02–0.64, p = 0.014). Anticipated stigma was significantly associated with higher ART uptake among those in the age group 60–69 (OR = 3.43, 95% CI 1.29–9.11, p = 0.013) (see Table A4). Marital status was significantly associated with higher ART uptake among those widowed in the age group 50–59 (OR = 4.14, 95% CI 1.05–16.23, p = 0.042). Employment was significantly associated with lower ART uptake among those retired in the age group 60–69 (OR = 0.36, 95% CI 0.14–0.93, p = 0.035). A significantly lower ART uptake was observed for those living in 7 + person households in the age group 70–79 (OR = 0.11, 95% CI 0.02–0.58, p = 0.009).

Social stigma was significantly associated with lower HIV testing among both men and women with a stigma score of 1(OR = 0.58, 95% CI 0.42–0.79, p = 0.001), (OR = 0.71, 95% CI 0.53–0.96, p = 0.026), score of 2 (OR = 0.64, 95% CI 0.43–0.96, p = 0.029), (OR = 0.58, 95% CI 0.41–0.83, p = 0.003) and score of 3 for men (OR = 0.44, 95% CI 0.26–0.76, p = 0.003) (see Table A5). Age group was significantly associated with lower testing among women in all age groups (OR = 0.55, 95% CI 0.35–0.87, p = 0.011), (OR = 0.59, 95% CI 0.36–0.95, p = 0.032), (OR = 0.30, 95% CI 0.18–0.51, p = 0.000), (OR = 0.21, 95% CI 0.12–0.37, p = 0.000) and for men only significantly associated with lower testing in 80 + age group (OR = 0.45, 95% CI 0.26–0.76, p = 0.003). Marital status was significantly associated with higher testing among both men and women, for those ever married (OR = 1.74, 95% CI 1.07–2.82, p = 0.026), (OR = 2.18, 95% CI 1.28–3.69, p = 0.004), (OR = 2.99, 95% CI 2.02–4.44, p = 0.000), (OR = 1.99, 95% CI 1.25–3.17, p = 0.004) and widowed (OR = 2.09, 95% CI 1.31–3.33, p = 0.002), (OR = 01.87, 95% CI 1.18–2.95, p = 0.008). Household size was significantly associated with less testing for men compared to women (OR = 0.51, 95% CI 0.32–0.81, p = 0.004), (OR = 0.65, 95% CI 0.43–0.98, p = 0.039), (OR = 0.53, 95% CI 0.34–0.82, p = 0.004), and significantly higher for men in the highest wealth index (OR = 1.65, 95% CI 1.14–2.38, p = 0.007) and significantly higher for women in the second wealth index (OR = 1.38, 95% CI 1.03–1.85, p = 0.033).

Anticipated stigma was significantly associated with higher HIV testing for both men and women, although this association was not significant (see Table A6). Age group was significantly associated with lower testing among women in all age groups (OR = 0.54, 95% CI 0.34–0.86, p = 0.009), (OR = 0.56, 95% CI 0.35–0.92, p = 0.021), (OR = 0.29, 95% CI 0.17–0.48, p = 0.000), (OR = 0.19, 95% CI 0.11–0.32, p = 0.000), and significantly lower for men only in the 70–79 (OR = 0.59, 95% CI 0.36–0.97, p = 0.038) and 80 + age group (OR = 0.41, 95% CI 0.24–0.70, p = 0.001). Marital status was significantly associated with higher testing for both men and women, for currently married (OR = 3.06, 95% CI 2.07–4.53, p = 0.000), (OR = 2.07, 95% CI 1.30–3.29, p = 0.002), widowed (OR = 2.11, 95% CI 1.33–3.35, p = 0.001), (OR = 1.92, 95% CI 1.21–3.02, p = 0.005), and separated or divorced (OR = 1.76, 95% CI 1.09–2.85, p = 0.021), (OR = 2.19, 95% CI 1.29–3.71, p = 0.004). Household size was significantly associated with less testing for men compared to women (OR = 0.53, 95% CI 0.34–0.85, p = 0.007), (OR = 0.67, 95% CI 0.45–1.01, p = 0.053), (OR = 0.54, 95% CI 0.35–0.84, p = 0.006). Wealth index was significantly associated with higher testing among men in the highest wealth index (OR = 1.71, 95% CI 1.19–2.46, p = 0.004) and for women in the second wealth index (OR = 1.41, 95% CI 1.05–1.89, p = 0.022).

Social stigma was significantly associated with lower ART uptake for men with a stigma score of 3 (OR = 0.28, 95% CI 0.08–0.97, p = 0.046) and women with a score of 2 (OR = 0.28, 95% CI 0.10–0.83, p = 0.022) (see Table A7). ART uptake was significantly higher among men in the age group 60–69 compared to women (OR = 2.61, 95% CI 1.01–6.78, p = 0.048). Being widowed was significantly associated with higher ART uptake among men (OR = 5.90, 95% CI 1.45–24.00, p = 0.013). Employment was significantly associated with lower ART uptake among women compared to men (OR = 0.34, 95% CI 0.18–0.68, p = 0.002), while living in a 7 + person household was significantly associated with lower ART uptake among men (OR = 0.30, 95% CI 0.10–0.90, p = 0.032). Anticipated stigma was significantly associated with higher ART uptake among men compared to women (OR = 2.35, 95% CI 1.07–5.14, p = 0.033) (see Table A8), with age group 60–69 also showing significantly higher ART uptake for men compared to women (OR = 2.61, 95% CI 1.00–6.79, p = 0.049). Being widowed and currently married or living with a partner was significantly associated with higher ART uptake among men compared to women (OR = 6.28, 95% CI 1.55–25.41, p = 0.010), (OR = 2.78, 95% CI 0.99–7.81, p = 0.053). Education and employment were significantly associated with lower ART uptake among women compared to men, in particular for those with some primary education and those employed (OR = 0.52, 95% CI 0.27–0.99, p = 0.048), (OR = 0.36, 95% CI 0.19–0.70, p = 0.003), and living in a 7 + person household was significantly associated with lower ART uptake among men compared to women (OR = 0.30, 95% CI 0.10–0.92, p = 0.035).

Discussion

This study examined the association between HIV-related stigma and HIV testing and ART uptake in a cohort of older adults in rural South Africa. We found that higher social stigma scores were associated with a significant decrease in the likelihood of ever testing for HIV among all participants with social stigma. This finding suggests that social stigma poses a significant barrier to testing behaviour among older adults. HIV testing is an important gateway to accessing HIV prevention and care and treatment services. However, HIV-related stigma is widely recognized as a major obstacle to successful HIV control efforts. Previous research has shown that stigma not only affects HIV testing uptake, but also creates challenges for PLWH in accessing care, starting treatment, and adhering to ART [4446]. Bessong et al. [47] asserts that limitations in access to HIV testing or treatment for PLWH due to stigma could affect the preventative impact of ART, making it essential to address HIV-related stigma to improve the effectiveness of HIV control initiatives.

Several studies have reported on the association between HIV-related stigma and uptake of HIV testing. Similar to the findings of this study, these studies have shown that stigma is a significant barrier to HIV testing [2631, 48, 49]. Studies from different countries, such as Botswana and Venezuela, have also highlighted stigma as the primary obstacle to HIV testing [50, 51]. Furthermore, systematic reviews from India and other regions have also consistently identified HIV-related stigma as a key reason for low HIV testing uptake and a common barrier to linkage to HIV care and accessing ART services [46, 5256], indicating that stigma influences every stage of the HIV care continuum. These findings collectively underscore the critical role of addressing HIV-related stigma to improve HIV testing uptake and care outcomes.

HIV-related stigma negatively influences HIV testing uptake in several ways. Stigma creates a fear of discrimination and negative social consequences for those perceived to have HIV. This fear may discourage people from getting tested as they may worry about being treated differently or ostracized if their HIV status becomes known. Findings from previous research [19, 30, 51, 53, 57] also suggest that fears surrounding the test and the possibility of a positive diagnosis, often due to stigma, also deter people from seeking HIV testing. HIV-related stigma can also lead to feelings of shame and guilt associated with HIV risk behaviors, and these feelings can discourage individuals engaging in risk behaviours from getting tested and treated for HIV as they may associate a positive result with personal failure of moral judgement. Stigma is also fueled by misunderstanding about HIV transmission [58]. Misconceptions about HIV transmission may lead some to believe they are not at risk and avoid testing. HIV-related stigma may also reduce social networks and social interactions for PLWH because of self-imposed social isolation and avoiding negative judgement and guilt related to HIV [39]. People may avoid testing as they fear losing social support or connections if diagnosed with HIV. Fear of disclosing HIV status to family, friends, or partners due to stigma is a significant barrier to testing. Studies revealed that the sharing of positive HIV status with family or friends may lead to social stigma [59] and isolation or exclusion by community [22, 60]. Therefore, individuals may choose to not get tested to avoid the potential consequences of having to disclose their status.

Cultural and religious beliefs can also contribute to HIV-related stigma, resulting in hesitancy in testing. In some communities, HIV/AIDS is blamed on witchcraft, spirits and supernatural forces [61], and still seen by some as a form of religious punishment for a culpable person, a curse from God or a sinner’s disease [62]. These stigmatizing beliefs can discourage individuals from seeking HIV testing and care, further perpetuating the negative impact of HIV-related stigma. Additionally, concerns about confidentiality of HIV tests results can contribute to lower uptake of HIV testing, consistent with [46, 57]. Individuals may fear that their HIV status will not be kept private, leading them to avoid testing altogether. HIV testing is the key entry point into the HIV care cascade, and without improvements in testing, it will be impossible to reach the UNAIDS 95–95–95 targets. Thus, addressing HIV-related stigma through awareness, education, and creating supportive environments is essential to encourage testing and increase the uptake of HIV testing among older adults. Furthermore, ensuring confidential, accessible and non-judgmental testing services can encourage individuals to get tested, and access care and support if needed.

The study found evidence supporting a negative association between HIV-related stigma and ART uptake among older adults living with HIV. Social stigma was significantly linked to lower levels of ART uptake, especially among those with a social stigma score of 2. This finding aligns with the results of two systematic reviews and meta-analyses studies, which also found significant correlations between HIV-related stigma and ART adherence [45, 63]. The studies indicated that HIV-related stigma negatively impacted adherence to ART by compromising general psychological processes, such as social support and adaptive coping. PLWH facing discrimination and rejection may experience reduced social support, which plays a crucial role in maintaining adherence. Previous research has also demonstrated the importance of social ties in promoting adherence, particularly in resource-limited settings [64]. HIV-related stigma can also hinder individuals’ ability to cope adaptively with the challenges of living with HIV, potentially affecting their medication adherence and overall well-being [45]. PLWH who experience enacted stigma and anticipated stigma may resort to concealing their status, leading to delays in treatment initiation and interruptions in treatment uptake. Stigma-related fears and concealment practices can disrupt continuity of care and medication adherence, posing challenges to effectively managing HIV. The study findings are also supported by other studies conducted in South Africa [65] and Tanzania [66] which also highlight how widespread HIV-related stigma affects HIV testing willingness and treatment adherence. ART uptake is crucial for improving the health outcomes of PLWH, but stigma can act as a barrier to its success. Addressing HIV-related stigma is essential, particularly for older adults, to enhance ART uptake and quality of life. Effective interventions that target HIV-related stigma are needed to improve ART uptake among older populations and promote better health outcomes.

In this study, there was a positive association between anticipated stigma and ART uptake, but it was not statistically significant. Previous research on the association between anticipated stigma and ART adherence has shown inconsistent results [24, 67]. Some studies found no association or a non-significant one [68, 69], while others observed both positive and negative associations [70, 71]. These inconsistencies may be due to variations in participants and measurement methods for anticipated stigma [24]. However, it is also possible that anticipated stigma's impact on ART adherence depends on other unmeasured psychosocial factors. For example, the study by [24] revealed that anticipated stigma was not significantly associated with ART non-adherence, but when accounting for medication concerns, anticipated stigma became associated with increased ART adherence. Future research on HIV-related stigma should use standardized measures of anticipated stigma and include prospective analyses to explore potential mediating variables.

The study also identified several key factors influencing HIV testing and ART uptake among older adults. Older age was associated with reduced HIV testing, consistent with other research showing lower testing rates among older individuals [72]. Lack of older adults HIV prevention programs, low risk perception, and stigma contribute to this trend [19, 57, 73]. The increasing number of PLWH aged 50 years and above highlights the need for integrating older adults into HIV prevention, care, and treatment programs to effectively address the HIV epidemic. Being ever married increased the likelihood of both HIV testing and ART uptake, consistent with other studies [7481] and possibly due to perceived risk within relationships and premarital HIV counselling and testing. Consistent with other studies [75, 78, 82, 83], higher educational levels were positively associated with HIV testing, likely because education influences health awareness and access to testing services [84, 85]. Wealthier individuals also had higher odds of HIV testing and ART uptake, in line with other studies [77, 8688]. Social stigma was found to be higher among older adults, in line with [89, 90]. HIV and ART status were significant predictors of stigma, and anticipated stigma was observed as a barrier to disclosing HIV status among older adults in the study.

Strengths and Limitations

This study's strengths include its integration into an old age cohort with a large sample size from an HDSS platform, allowing for generalizability to the study area's population. The longitudinal cohort design contributes to low rates of loss to follow-up, and the use of DBS provides biological measurements for HIV status, viral load, and ART. However, there are limitations in the study. We used self-reporting for HIV testing which may introduce social desirability bias. The cross-sectional design prevents causal interpretations of associations. Other dimensions of HIV-related stigma beyond social and anticipated stigma were not assessed. The assessment of anticipated stigma was limited to one question, which may not fully capture its complexity. Additionally, the measures of HIV stigma rely on self-reports of hypothetical scenarios, which might lead to misconceptions by respondents.

Conclusion

The study results indicate a significant negative influence of HIV-related stigma on HIV testing and ART uptake among older adults in rural South Africa. This emphasizes the need to address HIV-related stigma as a vital aspect on efforts to increase testing and treatment rates in this population. By implementing targeted interventions to combat stigma, we can make substantial progress towards achieving the UNAIDS 95–95–95 targets.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

The study participants, field staff and management are sincerely acknowledged for their respective contributions to the production of the data used in this study.

Author Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [NBM, DOK, FXGO, LM]. The first draft of the manuscript was written by [NBM] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Funding

Open access funding provided by University of the Witwatersrand. This work was supported by the National Institute on Aging at the National Institutes of Health (P01 AG041710), HAALSI-Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa). The HAALSI study is nested within the Agincourt Health and Demographic Surveillance System site, which is supported by the Wellcome Trust, UK (058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z), University of the Witwatersrand, Medical Research Council South Africa, the South African Department of Science and Technology (via the South African Population Research Infrastructure Network).

Declarations

Competing interests

The authors have no competing interests to declare that are relevant to the content of this article.

Ethical Approval

The HAALSI cohort study was approved by the Human Research Ethics committee of the Harvard University (protocol #IRB18-1214), University of the Witwatersrand (protocol #M180477), and Mpumalanga Province Department of Health (protocol #MP_201902_001).

Consent to Participate

Written informed consent was obtained from all participants prior to their participation in the study.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.UNAIDS. Global HIV Statistics-Fact Sheet 2023. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed 1 Aug 2023.
  • 2.Statistics South Africa. STATISTICAL RELEASE P0302: Mid-year population estimates. 2021. https://www.statssa.gov.za/publications/P0302/P03022021.pdf. Accessed 2 Sept 2022.
  • 3.UNAIDS. HIV AND AGING: A special supplement to the UNAIDS report on the global AIDS epidemic 2013. https://www.unaids.org/sites/default/files/media_asset/20131101_JC2563_hiv-and-aging_en_0.pdf. Accessed 5 Mar 2022.
  • 4.Gómez-Olivé FX, Angotti N, Houle B, Klipstein-Grobusch K, Kabudula C, Menken J, et al. Prevalence of HIV among those 15 and older in rural South Africa. AIDS Care. 2013;25(9):1122–1128. doi: 10.1080/09540121.2012.750710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wallrauch C, Bärnighausen T, Newell ML. HIV prevalence and incidence in people 50 years and older in rural South Africa. S Afr Med J. 2010;100(12):812–814. doi: 10.7196/samj.4181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gómez-Olivé FX, Houle B, Rosenberg M, Kabudula C, Mojola S, Rohr JK, et al. HIV incidence among older adults in a rural South African setting:2010–2015. J Acquir Immune Defic Syndr. 2020;85:18–22. doi: 10.1097/QAI.0000000000002404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Emlet CA. Experiences of stigma in older adults living with HIV/AIDS: A mixed-methods analysis. AIDS Patient Care STDS. 2007;21(10):740–752. doi: 10.1089/apc.2007.0010. [DOI] [PubMed] [Google Scholar]
  • 8.Lazarus JV, Nielsen K. HIV and people over 50 years old in Europe. HIV Med. 2010;11(7):479–481. doi: 10.1111/j.1468-1293.2009.00810.x. [DOI] [PubMed] [Google Scholar]
  • 9.Houle B, Mojola SA, Angotti N, Schatz E, Gómez-Olivé FX, Clark SJ, Williams, , et al. Sexual behavior and HIV risk across the life course in rural South Africa: trends and comparisons. AIDS Care. 2018;30(11):1435–43. doi: 10.1080/09540121.2018.1468008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rosenberg MS, Gómez-Olivé FX, Rohr JK, Houle BC, Kabudula C, Wagner RG, et al. Sexual behaviors and HIV status: a population-based study among older adults in rural South Africa. J Acquir Immune Defic Syndr. 2017;74(1):e9–e17. doi: 10.1097/QAI.0000000000001173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.UNAIDS. THE GAP REPORT 2014. https://www.unaids.org/sites/default/files/media_asset/12_Peopleaged50yearsandolder.pdf. Accessed 17 Apr 2022.
  • 12.Odor K. Elderly condom use and perception: a barrier to family planning and mitigation of HIV/AIDS in high risk urban slums in Nigeria. BMC Proc. 2011;5(S6):P290. doi: 10.1186/1753-6561-5-s6-p290. [DOI] [Google Scholar]
  • 13.Pilowsky D, Wu LT. Sexual risk behaviors and HIV risk among Americans aged 50 years or older: a review. Subst Abuse Rehabil. 2015;6:51–60. doi: 10.2147/sar.s78808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Stentagg M, Skär L, Berglund JS, Lindberg T. Cross-sectional study of sexual activity and satisfaction among older adult’s ≥ 60 years of age. Sex Med. 2021;9(2):100316. doi: 10.1016/j.esxm.2020.100316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lee DM, Nazroo J, O’Connor DB, Blake M, Pendleton N. Sexual health and well-being among older men and women in England: findings from the English Longitudinal Study of Ageing. Arch Sex Behav. 2016;45(1):133–144. doi: 10.1007/s10508-014-0465-1. [DOI] [PubMed] [Google Scholar]
  • 16.Simbayi L, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, Mabaso M, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017 : towards achieving the UNAIDS 90–90–90 targets. HSRC Press. 2019. https://hsrc.ac.za/uploads/pageContent/10779/SABSSM%20V.pdf. Accessed 5 May 2022.
  • 17.Chan BT, Tsai AC, Siedner MJ. HIV treatment scale-up and HIV-related stigma in sub-Saharan Africa: a longitudinal cross-country analysis. Am J Public Health. 2015;105(8):1581–1587. doi: 10.2105/AJPH.2015.302716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.UNAIDS. UNAIDS Data. 2019. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf. Accessed 21 Aug 2022.
  • 19.Youssef E, Cooper V, Delpech V, Davies K, Wright J. Barriers and facilitators to HIV testing in people age 50 and above: a systematic review. Clin Med. 2017;17(6):508–520. doi: 10.7861/clinmedicine. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Youssef E, Wright J, Delpech V, Davies K, Brown A, Cooper V, et al. Factors associated with testing for HIV in people aged ≥ 50 years: a qualitative study. BMC Public Health. 2018;18(1):1204. doi: 10.1186/s12889-018-6118-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.UNAIDS. Evidence for eliminating HIV-related stigma and discrimination—guidance for countries to implement effective programmes to eliminate HIV-related stigma and discrimination in six settings. 2020. https://www.unaids.org/sites/default/files/media_asset/eliminating-discrimination-guidance_en.pdf. Accessed 5 July 2023.
  • 22.Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–1177. doi: 10.1007/s10461-009-9593-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stangl AL, Brady L, Fritz K. Measuring HIV stigma and discrimination: Technical Brief. Washington, DC: International Center for Research on Women; 2012. https://www.icrw.org/wp-content/uploads/2017/07/STRIVE_stigma-brief-A4.pdf. Accessed 19 July 2023.
  • 24.Camacho G, Kalichman S, Katner H. Anticipated HIV-related stigma and HIV treatment adherence: the indirect effect of medication concerns. AIDS Behav. 2020;24(1):185–191. doi: 10.1007/s10461-019-02644-z. [DOI] [PubMed] [Google Scholar]
  • 25.Hutchinson P, Dhairyawan R. Shame, stigma, HIV: philosophical reflections. Med Humanit. 2017;43(4):225–230. doi: 10.1136/medhum-2016-011179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the internalized AIDS-related stigma scale. AIDS Care. 2009;21(1):87–93. doi: 10.1080/09540120802032627. [DOI] [PubMed] [Google Scholar]
  • 27.Saki M, Mohammad Khan Kermanshahi S, Mohammadi E, Mohraz M. Perception of patients with HIV/AIDS from stigma and discrimination. Iran Red Crescent Med J. 2015;17(6):e23638. doi: 10.5812/ircmj.23638v2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Golub SA, Gamarel KE. The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City. AIDS Patient Care STDS. 2013;27(11):621–627. doi: 10.1089/apc.2013.0245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hamilton A, Shin S, Taggart T, Whembolua GL, Martin I, Budhwani H, Conserve D. HIV testing barriers and intervention strategies among men, transgender women, female sex workers and incarcerated persons in the Caribbean: a systematic review. Sex Transm Infect. 2020;96(3):189–196. doi: 10.1136/sextrans-2018-053932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hlongwa M, Mashamba-Thompson T, Makhunga S, Hlongwana K. Barriers to HIV testing uptake among men in sub-Saharan Africa: a scoping review. Afr J AIDS Res. 2020;19(1):13–23. doi: 10.2989/16085906.2020.1725071. [DOI] [PubMed] [Google Scholar]
  • 31.Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79(6):442–447. doi: 10.1136/sti.79.6.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cahill S, Valadéz R. Growing older with HIV/AIDS: New public health challenges. Am J Public Health. 2013;103(3):e7–e15. doi: 10.2105/AJPH.2012.301161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kahn K, Collinson MA, Gómez-Olivé FX, Mokoena O, Twine R, Mee P, et al. Profile: Agincourt health and socio-demographic surveillance system. Int J Epidemiol. 2012;41(4):988–1001. doi: 10.1093/ije/dys115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–965. doi: 10.1126/science.1230413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kabudula CW, Houle B, Collinson MA, Kahn K, Gómez-Olivé FX, Clark SJ, Tollman S. Progression of the epidemiological transition in a rural South African setting: findings from population surveillance in Agincourt, 1993–2013. BMC Public Health. 2017;17(1):424. doi: 10.1186/s12889-017-4312-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gómez-Olivé F, Montana L, Wagner R, Kabudula C, Rohr JK, Kahn K, et al. Cohort profile: health and ageing in Africa: a longitudinal study of an indepth community in South Africa (HAALSI) Int J Epidemiol. 2018;47(3):689–690. doi: 10.1093/ije/dyx247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.UNAIDS. National AIDS Programmes: A Guide to Monitoring and Evaluation. 2000. https://www.unaids.org/sites/default/files/media_asset/jc427-mon_ev-full_en_0.pdf. Accessed 2 Feb 2022.
  • 38.Link BG, Cullen FT, Frank J, Wozniak JF. The social rejection of former mental patients: understanding why labels matter. Am J Sociol. 1987;92(6):1461–1500. doi: 10.1086/228672. [DOI] [Google Scholar]
  • 39.Chan BT, Tsai AC. HIV stigma trends in the general population during antiretroviral treatment expansion: Analysis of 31 countries in sub-Saharan Africa, 2003–2013. J Acquir Immune Defic Syndr. 2016;72(5):558–564. doi: 10.1097/QAI.0000000000001011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wolfe WR, Weiser SD, Leiter K, Steward WT, Percy-de Korte F, Phaladze N, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98(10):1865–1871. doi: 10.2105/AJPH.2007.122044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Link BG. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Sociol Rev. 1987;52(1):96–112. doi: 10.2307/2095395. [DOI] [Google Scholar]
  • 42.Manne-Goehler J, Rohr J, Montana L, Siedner M, Harling G, Gómez-Olivé FX, et al. ART denial: results of a home-based study to validate self-reported antiretroviral use in rural South Africa. AIDS Behav. 2019;23(8):2072–2078. doi: 10.1007/s10461-018-2351-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.StataCorp. Stata Statistical Software: Release 17. College Station: International Center for Research on Women; 2021.
  • 44.Ahmed S, Autrey J, Katz IT, Fox MP, Rosen S, Onoya D, et al. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc Sci Med. 2018;213:72–84. doi: 10.1016/j.socscimed.2018.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640. doi: 10.7448/IAS.16.3.18640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa. BMC Public Health. 2013;13:220. doi: 10.1186/1471-2458-13-220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bessong PO, Matume ND, Tebit DM. Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview. AIDS Res Ther. 2021;18(1):1. doi: 10.1186/s12981-020-00324-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Khan R, Yassi A, Engelbrecht MC, Nophale L, van Rensburg AJ, Spiegel J. Barriers to HIV counselling and testing uptake by health workers in three public hospitals in Free State Province, South Africa. AIDS Care. 2015;27(2):198–205. doi: 10.1080/09540121.2014.951308. [DOI] [PubMed] [Google Scholar]
  • 49.Mambanga P, Sirwali RN, Tshitangano T. Factors contributing to men’s reluctance to seek HIV counselling and testing at primary health care facilities in Vhembe District of South Africa. Afr J Primary Health Care Fam Med. 2016;8(2):e1–e7. doi: 10.4102/phcfm.v8i2.996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bonjour MA, Montagne M, Zambrano M, Molina G, Lippuner C, Wadskier FG, et al. Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case–case comparison. AIDS Res Ther. 2008;5:6. doi: 10.1186/1742-6405-5-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wolfe WR, Weiser SD, Bangsberg DR, Thior I, Makhema JM, Dickinson DB, et al. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006;18(8):931–933. doi: 10.1080/09540120500333558. [DOI] [PubMed] [Google Scholar]
  • 52.Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS survival and delayed diagnosis among Hispanics in the United States. J Immigr Minor Health. 2012;14(1):65–81. doi: 10.1007/s10903-011-9497-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Evangeli M, Pady K, Wroe AL. Which psychological factors are related to HIV testing? A quantitative systematic review of global studies. AIDS Behav. 2016;20(4):880–918. doi: 10.1007/s10461-015-1246-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Deblonde J, De Koker P, Hamers FF, Fontaine J, Luchters S, Temmerman M. Barriers to HIV testing in Europe: a systematic review. Eur J Public Health. 2010;20(4):422–432. doi: 10.1093/eurpub/ckp231. [DOI] [PubMed] [Google Scholar]
  • 55.Wei C, Cheung DH, Yan H, Li J, Shi LE, Raymond HF. The impact of homophobia and HIV stigma on HIV testing uptake among Chinese men who have sex with men: a mediation analysis. J Acquir Immune Defic Syndr (1988) 2016;71(1):87–93. doi: 10.1097/QAI.0000000000000815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bharat S. A systematic review of HIV/AIDS-related stigma and discrimination in India: current understanding and future needs. SAHARA J. 2011;8(3):138–149. doi: 10.1080/17290376.2011.9724996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Schatz E, Houle B, Mojola SA, Angotti N, Williams J. How to “live a good life”: aging and HIV testing in rural South Africa. J Aging Health. 2019;31(4):709–732. doi: 10.1177/0898264317751945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Boushab BM, Fall-Malick F-Z, Ould Cheikh Melaïnine ML, Basco LK. Forms of stigma and discrimination in the daily lives of HIV-positive individuals in Mauritania. Open AIDS J. 2017;11:12–17. doi: 10.2174/1874613601711010012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–529. doi: 10.1002/nur.10011. [DOI] [PubMed] [Google Scholar]
  • 60.Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care. 2009;21(6):742–753. doi: 10.1080/09540120802511877. [DOI] [PubMed] [Google Scholar]
  • 61.Kalichman SC, Simbayi L. Traditional beliefs about the cause of AIDS and AIDS-related stigma in South Africa. AIDS Care. 2004;16(5):572–580. doi: 10.1080/09540120410001716360. [DOI] [PubMed] [Google Scholar]
  • 62.Kopelman LM. If HIV/AIDS is punishment, who is bad? J Med Philos. 2002;27(2):231–243. doi: 10.1076/jmep.27.2.231.2987. [DOI] [PubMed] [Google Scholar]
  • 63.Rueda S, Mitra S, Chen S, Gogolishvili D, Globerman J, Chambers L, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453. doi: 10.1136/bmjopen-2016-011453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, et al. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013;46(3):285–294. doi: 10.1007/s12160-013-9514-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Adeniyi OV, Ajayi AI, ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(1):175. doi: 10.1186/s12879-018-3087-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF International. Tanzania HIV/AIDS and Malaria Indicator Survey 2011–12: key findings. Dar es Salaam: TACAIDS, ZAC, NBS, OCGS, and ICF International; 2013. https://www.dhsprogram.com/pubs/pdf/SR196/SR196.pdf. Accessed Mar 2022.
  • 67.Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50. doi: 10.1007/s10461-015-1164-1. [DOI] [PubMed] [Google Scholar]
  • 68.Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–1795. doi: 10.1007/s10461-013-0437-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care. 2010;22(3):381–389. doi: 10.1080/09540120903193708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20(10):1053–1056. doi: 10.1089/aid.2004.20.1053. [DOI] [PubMed] [Google Scholar]
  • 71.Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria. AIDS Patient Care STDS. 2013;27(1):55–64. doi: 10.1089/apc.2012.0150. [DOI] [PubMed] [Google Scholar]
  • 72.Ford CL, Godette DC, Mulatu MS, Gaines TL. Recent HIV testing prevalence, determinants, and disparities among US older adult respondents to the behavioral risk factor surveillance system. Sex Transm Dis. 2015;42(8):405–410. doi: 10.1097/OLQ.0000000000000305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Lekas HM, Schrimshaw EW, Siegel K. Pathways to HIV testing among adults aged fifty and older with HIV/AIDS. AIDS Care. 2005;17(6):674–687. doi: 10.1080/09540120412331336670. [DOI] [PubMed] [Google Scholar]
  • 74.Ayiga N, Nambooze H, Nalugo S, Kaye D, Katamba A. The impact of HIV/AIDS stigma on HIV counseling and testing in a high HIV prevalence population in Uganda. Afr Health Sci. 2013;13(2):278–286. doi: 10.4314/ahs.v13i2.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Deynu M, Agyemang K, Anokye N. Factors associated with HIV testing among reproductive women aged 15–49 years in the Gambia: analysis of the 2019–2020 Gambian Demographic and Health Survey. Int J Environ Res Public Health. 2022;19(8):4860. doi: 10.3390/ijerph19084860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Desta WG, Sinishaw MA, Bizuneh KD. Factors affecting utilization of voluntary HIV counseling and testing services among teachers in Awi Zone, Northwest Ethiopia. AIDS Res Treat. 2017 doi: 10.1155/2017/9034282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Erena AN, Shen G, Lei P. Factors affecting HIV counselling and testing among Ethiopian women aged 15–49. BMC Infect Dis. 2019;19(1):1076. doi: 10.1186/s12879-019-4701-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Jude O, Nelson O, Katagwa I. Socio-economic and demographic factors associated with never having tested for HIV among sexually active men across the four administrative regions of Uganda. BMC Public Health. 2021;21(1):2301. doi: 10.1186/s12889-021-12384-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Mahande MJ, Phimemon RN, Ramadhani HO. Factors associated with changes in uptake of HIV testing among young women (aged 15–24) in Tanzania from 2003 to 2012. Infect Dis Poverty. 2016;5(1):92. doi: 10.1186/s40249-016-0180-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Qiao S, Zhang Y, Li X, Menon JA. Facilitators and barriers for HIV-testing in Zambia: a systematic review of multi-level factors. PLoS ONE. 2018;13(2):e0192327. doi: 10.1371/journal.pone.0192327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Kubai PK, Kubai P, Kei R, Muchiri E, Mutema A, Karani C. Factors influencing anti-retroviral therapy uptake among HIV positive and exposed children aged below 14 years in Meru North District, Kenya. East Afr Med J. 2018;95:1125–1133. [Google Scholar]
  • 82.Bayani A, Ghiasvand H, Rezaei O, Fattah Moghaddam L, Noroozi A, Ahounbar E, et al. Factors associated with HIV testing among people who inject drugs: a meta-analysis. J Addict Dis. 2020;38(3):361–374. doi: 10.1080/10550887.2020.1771235. [DOI] [PubMed] [Google Scholar]
  • 83.Worku MG, Tesema GA, Teshale AB. Prevalence and associated factors of HIV testing among reproductive-age women in eastern Africa: multilevel analysis of demographic and health surveys. BMC Public Health. 2021;21(1):1262. doi: 10.1186/s12889-021-11292-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Hensen B, Lewis JJ, Schaap A, Tembo M, Mutale W, Weiss HA, et al. Factors associated with HIV-testing and acceptance of an offer of home-based testing by men in rural Zambia. AIDS Behav. 2015;19(3):492–504. doi: 10.1007/s10461-014-0866-0. [DOI] [PubMed] [Google Scholar]
  • 85.Agegnehu CD, Geremew BM, Sisay MM, Muchie KF, Engida ZT, Gudayu TW, et al. Determinants of comprehensive knowledge of HIV/AIDS among reproductive age (15–49 years) women in Ethiopia: further analysis of 2016 Ethiopian demographic and health survey. AIDS Res Ther. 2020;17(1):51. doi: 10.1186/s12981-020-00305-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bhattarai N, Bam K, Acharya K, Thapa R, Shrestha B. Factors associated with HIV testing and counselling services among women and men in Nepal: a cross-sectional study using data from a nationally representative survey. BMJ Open. 2021;11(12):e049415. doi: 10.1136/bmjopen-2021-049415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Somefun OD, Wandera SO, Odimegwu C. Media exposure and HIV testing among youth in sub-Saharan Africa: evidence from Demographic and Health Surveys (DHS) SAGE Open. 2019 doi: 10.1177/2158244019851551. [DOI] [Google Scholar]
  • 88.Exavery A, Charles J, Kuhlik E, Barankena A, Ally A, Mbwambo T, et al. Correlates of uptake of antiretroviral therapy in HIV-positive orphans and vulnerable children aged 0–14 years in Tanzania. HIV AIDS (Auckl) 2020;12:233–241. doi: 10.2147/HIV.S259074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Ncitakalo N, Mabaso M, Joska J, Simbayi L. Factors associated with external HIV-related stigma and psychological distress among people living with HIV in South Africa. SSM Popul Health. 2021;14:100809. doi: 10.1016/j.ssmph.2021.100809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Visser MJ, Makin JD, Vandormael A, Sikkema KJ, Forsyth BWC. HIV/AIDS stigma in a South African community. AIDS Care. 2009;21(2):197–206. doi: 10.1080/09540120801932157. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from AIDS and Behavior are provided here courtesy of Springer

RESOURCES